-
SHIRLEY LI
Counsel·
Beijing
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
MS. LI SPECIALIZES IN CORPORATE M&A, CAPITAL MARKETS, PRIVATE EQUITY INVESTMENT AND GENERAL CORPORATE MATTERS.
Education
Peking University, School of Law, LL.M.
Peking University, Yuanpei College, LL.B.
Professional Qualification
Admitted to practice in the PRC
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Represented InnoCare Pharma in its IPO on the Sci-Tech Board of the Shanghai Stock Exchange, and provided ongoing legal services for the Company
- Represented BeiGene in its IPO on the Sci-Tech Board of the Shanghai Stock Exchange
- Represented Alibaba Group in its issuance of offshore exchangeable bonds and convertible bonds
- Represented multiple enterprises in manufacturing technology, autonomous driving, healthcare sectors in their offshore IPOs (ongoing)
- Represented the underwriters in connection with the major asset restructuring of Minjiang Hydropower
- Represented Chongho Bridge and various other China-based companies in their pre-IPO restructuring and financing
- Represented the Seller in connection with the Shanghai Airport’s acquisition of relevant equity interests in Sunrise Duty Free
- Represented the Seller Morgan Stanley in connection with the transfer of control over Huai'an Huaiyin Hospital to China Resources Medical
- Represented the Seller Huang Jihuang in connection with Yum China's acquisition of Huang Jihuang
- Represented Xinghaitu, an embodied intelligence enterprise, in its multiple rounds of equity financing and the ESOP arrangement
- Represented Shimo Microelectronics, Rankyee Technology and Migrasome Therapeutics in their multiple rounds of equity financing, ESOP arrangement, and provided ongoing legal services for the relevant enterprises
- Provided legal services for Beijing Academy of Artificial Intelligence (BAAI), a research institution in the AI field
- Represented Alibaba Group in a series of equity investment and acquisition transactions in Nreal and Honor The Unknown, etc.
- Represented Hillhouse Capital, Boyu Capital, CMC Capital, Primavera Capital and Shunwei Capital in a series of equity investment and acquisition transactions
- Represented Taikang Insurance Group in a series of equity investment and acquisition transactions in third-party payment companies, doctor group companies and medical testing enterprises, etc.
- Represented CICC Capital, Kunlun Capital, China Mobile Hechuang and other investors in a series of equity investment transactions in Shandong Future Robot, Shudun Technology and Knownsec
- Represented Aptiv in its investment in Maxieye, a domestic autonomous driving enterprise
- Represented Medtronic Group in its investment in Surgerii, a medical surgical robot enterprise
- Represented Beijing Science and Technology Innovation Fund, China Mobile Capital’s fund in their LP investments in multiple funds managed by Legend Capital, Qiming Venture Partners, Sequoia Capital, China Capital Management Co., Ltd., 3E Bioventures, Alwin Capital, Essential Capital, Soaring Capital, Chenshan Capital and other fund managers
- Provided legal services for multiple state-owned enterprises including China Reform
